20Lighter Announces Presentation of Clinical Data at the AHA Hypertension 2019 Scientific Sessions

By: 20Lighter, LLC
Spread the Word
Listed Under

* Obesity

* Health

* Boca Raton - Florida - US

BOCA RATON, Fla. - Sept. 6, 2019 - PRLog -- 20Lighter, LLC, a comprehensive weight loss program focused on the reduction of visceral fat, announced today a presentation to be given by 20Lighter CMO & Co-Founder Dr. Gerry Dembrowski at the American Heart Association's Hypertension 2019 Scientific Sessions held in New Orleans, LA, on September 5-8, 2019. Considered one of the most important medical meetings on this subject in the world, the conference includes oral and poster presentations selected from abstracts submitted by clinical and basic researchers, followed by discussions led by leading authorities.

Saturday, September 7, 2019
1:30 PM – 3:00 PM ET

Significant Reduction of Visceral Adiposity in Hypertensive Participants of Doctor-Supervised, Intense Weight Loss Program

According to new statistics from the American Heart Association, nearly half of all adults in the US have high blood pressure and/or are taking antihypertensive medication. Perhaps even more alarming is that >45% of those with hypertension do not have it controlled. These statistics along with the fact that hypertension is the most common cause of cardiovascular disease-related death, demonstrate a need for effective non-pharmacological antihypertensive strategies. Studies show the amount of adipose tissue accumulating in the abdominal viscera exerts a graded influence on blood pressure. Few strategies exist targeting visceral fat as a means to reduce the risk of hypertension, cardiovascular disease, and metabolic syndrome. The presentation showed statistically significant and clinically meaningful reductions in body weight, BMI, body fat, and visceral adiposity for both hypertension and non-hypertension groups.

About 20Lighter, LLC

20Lighter is a holistic, lifestyle transformation solution inspiring unprecedented client engagement & incorporating cutting edge, industry leading health-related and quality of life outcomes that result in a fuller, happier life experience.

Our unique doctor supervised, patent-pending weight loss program has benefited clients looking to prevent weight-related illnesses, and had major impact on those who were already dealing with weight related health issues including type 2 diabetes, hypertension, high cholesterol, gout, sleep apnea, and metabolic syndrome.

In contrast to gimmick diets and quick fixes that produce nothing but a temporary change on the scale, the 20Lighter Program has a profound effect on inflammation in the Central Nervous System and gastrointestinal tract which leads to visceral fat accumulation & metabolic disease. The 20Lighter Program is the only program to incorporate natural strategies to address dietary inflammation, the fundamental cause of weight gain, regain after weight loss and metabolic diseases associated with fat storage. At 20Lighter we are laser-focused, we do one thing and do it extremely well…  we change lives by improving health, physical and mental well-being.

Media Contact
Jessica W. Barnes, PhD
CEO & Co-founder
Email:***@20lighter.com Email Verified
Location:Boca Raton - Florida - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse

Like PRLog?
Click to Share